세계의 전기의료/생체전기의료 시장 규모 조사 : 제품 유형별, 기기 유형별, 용도별, 최종 사용자별, 지역별 예측(2022-2032년)

The Global Electroceuticals/Bioelectric Medicine Market is valued at approximately USD 21.27 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.47% over the forecast period 2024-2032. Electroceuticals, which leverage electrical impulses to modulate neural circuits, tissues, or organs for therapeutic purposes, are increasingly gaining traction as innovative solutions for various medical conditions. This non-pharmacological approach offers promising treatments for chronic pain, neurological disorders, and psychiatric conditions, thus driving market growth. The growing geriatric population, projected to reach 1.4 billion people aged 60 and over by 2030 according to the World Health Organization (WHO), is a pivotal driver of the electroceuticals market. This demographic shift highlights the increasing prevalence of cardiovascular disorders and Parkinson's disease, necessitating advanced therapeutic technologies such as electroceuticals.

The market is also witnessing significant product innovation and regulatory support, fostering the availability of advanced electroceutical devices. For instance, the FDA approvals for Medtronic Plc's Micra AV and Boston Scientific's WaveWriter Alpha portfolio underscore the advancements in the field, bolstering market confidence and adoption. Additionally, the rise in minimally invasive procedures, government initiatives for medical device development, and advancements in healthcare technology further propel market growth. However, competition from pharmaceuticals and limited reimbursement policies pose challenges to market growth. Strategic positioning, advocating for improved reimbursement, and demonstrating cost-effectiveness are essential to overcoming these obstacles.

The key regions considered for the global electroceuticals/Bioelectric Medicine market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2022, attributed to well-established healthcare infrastructure, high healthcare spending, and extensive adoption of advanced therapeutic technologies. The region has a significant patient population suffering from chronic diseases such as cardiovascular disorders, neurological conditions, and chronic pain, which drive the demand for electroceutical therapies. Moreover, North America is home to numerous leading biotechnology and medical device companies that are actively involved in the research, development, and commercialization of electroceutical devices. Asia-Pacific is expected to exhibit the fastest growth during the forecast period, driven by robust economic development, expanding population, and improving healthcare infrastructure.

Major market players included in this report are:

• Boston Scientific Corporation
• Medtronic Plc
• LivaNova PLC
• Abbott Laboratories
• Cochlear Limited
• Biotronik SE & Co. KG
• Nevro Corp.
• Second Sight Medical Products, Inc.
• Inspire Medical Systems, Inc.
• ElectroCore, Inc.
• MicroPort Scientific Corporation
• NeuroPace, Inc.
• Nuvectra Corporation
• Axonics Modulation Technologies, Inc.
• Mainstay Medical International plc

The detailed segments and sub-segment of the market are explained below:

By Product:

• Cardiac Pacemakers & Implantable Cardioverter Defibrillators
• Cochlear Implants
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Others

By Device Type:

• Implantable Devices
• Non-invasive Devices

By Application:

• Arrhythmia
• Sensorineural Hearing Loss
• Epilepsy
• Parkinson's Disease
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLATAM
• Middle East & Africa
• South Africa
• Saudi Arabia
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Electroceuticals/Bioelectric Medicine Market Executive Summary

• 1.1. Global Electroceuticals/Bioelectric Medicine Market Size & Forecast (2022- 2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Device Type
  • 1.3.3. By Application
  • 1.3.4. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Electroceuticals/Bioelectric Medicine Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Electroceuticals/Bioelectric Medicine Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Growing geriatric population
  • 3.1.2. Rise in cardiovascular and neurological disorders
  • 3.1.3. Increase in minimally invasive procedures
• 3.2. Market Challenges
  • 3.2.1. Competition from pharmaceuticals
  • 3.2.2. Limited reimbursement policies
• 3.3. Market Opportunities
  • 3.3.1. Technological advancements in electroceuticals
  • 3.3.2. Increasing regulatory support

Chapter 4. Global Electroceuticals/Bioelectric Medicine Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Electroceuticals/Bioelectric Medicine Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Electroceuticals/Bioelectric Medicine Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • 5.2.2. Cochlear Implants
  • 5.2.3. Spinal Cord Stimulators
  • 5.2.4. Deep Brain Stimulators
  • 5.2.5. Vagus Nerve Stimulators
  • 5.2.6. Sacral Nerve Stimulators
  • 5.2.7. Others

Chapter 6. Global Electroceuticals/Bioelectric Medicine Market Size & Forecasts by Device Type 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Electroceuticals/Bioelectric Medicine Market: Device Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Implantable Devices
  • 6.2.2. Non-invasive Devices

Chapter 7. Global Electroceuticals/Bioelectric Medicine Market Size & Forecasts by Application 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Electroceuticals/Bioelectric Medicine Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Arrhythmia
  • 7.2.2. Sensorineural Hearing Loss
  • 7.2.3. Epilepsy
  • 7.2.4. Parkinson's Disease
  • 7.2.5. Others

Chapter 8. Global Electroceuticals/Bioelectric Medicine Market Size & Forecasts by End User 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global Electroceuticals/Bioelectric Medicine Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 8.2.1. Hospitals
  • 8.2.2. Ambulatory Surgical Centers
  • 8.2.3. Others

Chapter 9. Global Electroceuticals/Bioelectric Medicine Market Size & Forecasts by Region 2022-2032

• 9.1. North America Electroceuticals/Bioelectric Medicine Market
  • 9.1.1. U.S. Electroceuticals/Bioelectric Medicine Market
    • 9.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 9.1.1.2. Device Type breakdown size & forecasts, 2022-2032
    • 9.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 9.1.1.4. End User breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada Electroceuticals/Bioelectric Medicine Market
    • 9.1.2.1. Product breakdown size & forecasts, 2022-2032
    • 9.1.2.2. Device Type breakdown size & forecasts, 2022-2032
    • 9.1.2.3. Application breakdown size & forecasts, 2022-2032
    • 9.1.2.4. End User breakdown size & forecasts, 2022-2032
  • 9.1.3. Mexico Electroceuticals/Bioelectric Medicine Market
    • 9.1.3.1. Product breakdown size & forecasts, 2022-2032
    • 9.1.3.2. Device Type breakdown size & forecasts, 2022-2032
    • 9.1.3.3. Application breakdown size & forecasts, 2022-2032
    • 9.1.3.4. End User breakdown size & forecasts, 2022-2032
• 9.2. Europe Electroceuticals/Bioelectric Medicine Market
  • 9.2.1. Germany Electroceuticals/Bioelectric Medicine Market
  • 9.2.2. France Electroceuticals/Bioelectric Medicine Market
  • 9.2.3. UK Electroceuticals/Bioelectric Medicine Market
  • 9.2.4. Italy Electroceuticals/Bioelectric Medicine Market
  • 9.2.5. Spain Electroceuticals/Bioelectric Medicine Market
  • 9.2.6. Rest of Europe Electroceuticals/Bioelectric Medicine Market
• 9.3. Asia-Pacific Electroceuticals/Bioelectric Medicine Market
  • 9.3.1. China Electroceuticals/Bioelectric Medicine Market
  • 9.3.2. India Electroceuticals/Bioelectric Medicine Market
  • 9.3.3. Japan Electroceuticals/Bioelectric Medicine Market
  • 9.3.4. Australia Electroceuticals/Bioelectric Medicine Market
  • 9.3.5. South Korea Electroceuticals/Bioelectric Medicine Market
  • 9.3.6. Rest of Asia Pacific Electroceuticals/Bioelectric Medicine Market
• 9.4. Latin America Electroceuticals/Bioelectric Medicine Market
  • 9.4.1. Brazil Electroceuticals/Bioelectric Medicine Market
  • 9.4.2. Colombia Electroceuticals/Bioelectric Medicine Market
  • 9.4.3. Argentina Electroceuticals/Bioelectric Medicine Market
  • 9.4.4. Rest of Latin America Electroceuticals/Bioelectric Medicine Market
• 9.5. Middle East & Africa Electroceuticals/Bioelectric Medicine Market
  • 9.5.1. GCC Electroceuticals/Bioelectric Medicine Market
  • 9.5.2. South Africa Electroceuticals/Bioelectric Medicine Market
  • 9.5.3. North Africa Electroceuticals/Bioelectric Medicine Market
  • 9.5.4. Rest of Middle East & Africa Electroceuticals/Bioelectric Medicine Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Abbott Laboratories
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. Cochlear Limited
  • 10.3.3. Biotronik SE & Co. KG
  • 10.3.4. Nevro Corp.
  • 10.3.5. Second Sight Medical Products, Inc.
  • 10.3.6. Inspire Medical Systems, Inc.
  • 10.3.7. ElectroCore, Inc.
  • 10.3.8. MicroPort Scientific Corporation
  • 10.3.9. NeuroPace, Inc.
  • 10.3.10. Nuvectra Corporation
  • 10.3.11. Axonics Modulation Technologies, Inc.
  • 10.3.12. Mainstay Medical International plc
  • 10.3.12. Boston Scientific Corporation
  • 10.3.12. Medtronic Plc
  • 10.3.12. LivaNova PLC

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes